Statements (98)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Biology
|
| gptkbp:associated_with |
increased mortality
malnutrition antibiotic resistance dehydration sepsis intestinal perforation hospital readmissions increased healthcare costs inflammatory response increased morbidity biofilm formation healthcare-associated infections gastrointestinal complications chronic diarrhea spore formation toxin production toxic megacolon community-associated infections hospital outbreaks long-term sequelae pseudomembranous colitis recurrence of infection |
| gptkbp:can_be_spread_through |
contaminated surfaces
|
| gptkbp:can_cause |
diarrhea
|
| gptkbp:can_cause_severe |
intestinal inflammation
|
| gptkbp:can_create |
spores
|
| gptkbp:can_lead_to |
colitis
|
| gptkbp:can_recur_after_treatment |
infections
|
| gptkbp:cause |
gptkb:Clostridium_difficile_infection
morbidity and mortality healthcare-associated infections immunocompromised patients antibiotic-associated diarrhea |
| gptkbp:communication_system |
fecal-oral route
|
| gptkbp:complications |
toxic megacolon
|
| gptkbp:diagnosis |
endoscopy
stool tests PCR test stool test other gastrointestinal infections |
| gptkbp:genus |
gptkb:Biology
|
| gptkbp:has_a_focus_on |
gptkb:guidelines
antimicrobial stewardship programs |
| https://www.w3.org/2000/01/rdf-schema#label |
C. difficile
|
| gptkbp:is_a_significant_concern_in |
long-term care facilities
|
| gptkbp:is_a_subject_of |
clinical trials
public health research |
| gptkbp:is_associated_with |
increased healthcare utilization
increased mortality rates antibiotic use |
| gptkbp:is_common_in |
older adults
|
| gptkbp:is_found_in |
human intestines
|
| gptkbp:is_involved_in |
biofilm formation
|
| gptkbp:is_known_for |
high recurrence rate
|
| gptkbp:is_linked_to |
prolonged hospital stays
|
| gptkbp:is_managed_by |
probiotics
|
| gptkbp:is_monitored_by |
healthcare organizations
|
| gptkbp:is_often_seen_in |
hospitals and nursing homes
|
| gptkbp:is_part_of_the_normal_flora_in |
some individuals
|
| gptkbp:is_recognized_as |
gptkb:1935
|
| gptkbp:is_recognized_by |
PCR testing
|
| gptkbp:is_studied_in |
microbiology
|
| gptkbp:is_vulnerable_to |
many antibiotics
|
| gptkbp:issues |
public health officials
infection control practices |
| gptkbp:notable_contributor |
healthcare costs
|
| gptkbp:notable_production |
two main toxins
|
| gptkbp:prevalence |
increasing in recent years
|
| gptkbp:prevention |
hand hygiene
antibiotic stewardship hygiene measures contact precautions |
| gptkbp:produces |
toxins
|
| gptkbp:replaces |
environmental surfaces
|
| gptkbp:risk_factor |
hospitalization
long-term care facilities antibiotic use immunocompromised state age over 65 previous C. difficile infection |
| gptkbp:scientific_classification |
Firmicutes phylum
an opportunistic pathogen |
| gptkbp:seed_dispersal |
4.3 million base pairs
|
| gptkbp:sensitivity |
hand sanitizers containing alcohol
|
| gptkbp:symptoms |
abdominal pain
diarrhea |
| gptkbp:targets |
vaccine development
|
| gptkbp:transmission |
fecal-oral route
|
| gptkbp:treatment |
gptkb:fidaxomicin
antibiotics probiotics metronidazole vancomycin fecal microbiota transplantation |
| gptkbp:type_of |
anaerobic bacterium
|
| gptkbp:bfsParent |
gptkb:SYN-004
|
| gptkbp:bfsLayer |
7
|